Opus Genetics announced positive 3- and 6-month results from the low-dose cohort 1 of BIRD-1, the ongoing phase 1/2 ...
Please provide your email address to receive an email when new articles are posted on . Best corrected visual acuity was the only visual function test ready for use in a diabetic retinal disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results